BARCELONA, September 1 /PRNewswire/ --
- Surveys Establish Residual Vascular Risk is Associated With Atherogenic Dyslipidemia Suggesting the Need to Reconsider Approach to Management of Lipids
- Residual Risk Reduction initiative (R3i) Foundation Presents Early Findings From Unique Global Investigation Into Effects on Residual Macrovascular and Microvascular Risk
Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.
To view the Multimedia News Release, please click:
This has been demonstrated in new analyses of the landmark Prospective Cardiovascular Munster (PROCAM) and the REsiduAl risk Lipids and Standard Therapies (REALIST) surveys, the latter funded and conducted by the Residual Risk Reduction Initiative Foundation or R3i. These data have been presented today at the European Society of Cardiology (ESC) congress.
The final objective of the R3i is to significantly reduce the incidence of both major macrovascular events and microvascular complications (e.g. in patients with type 2 diabetes or affected by the metabolic syndrome) beyond what is already achieved with current treatments.,
Earlier studies, largely conducted in patients treated with statins show that lowering LDL-C to currently recognized goals only reduces the relative risk of macrovascular disease by about 23 percent.
"The residual vascular risk driven by the increasing epidemic of obesity,
metabolic syndrome and type 2 diabetes is not being adequately
|SOURCE Residual Risk Reduction Initiative Foundation|
Copyright©2009 PR Newswire.
All rights reserved